BrainStorm Cell Therapeutics
BCLI
#10399
Rank
โ‚น0.59 B
Marketcap
โ‚น53.96
Share price
0.00%
Change (1 day)
-59.66%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Net assets

Net assets on the balance sheet as of June 2025 : -โ‚น0.55 Billion

According to BrainStorm Cell Therapeutics's latest financial reports the company has -โ‚น0.55 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BrainStorm Cell Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚น0.67 Billion64.69%
2023-12-31$-โ‚น0.41 Billion62.1%
2022-12-31$-โ‚น0.25 Billion-117.33%
2021-12-31$โ‚น1.43 B-44.49%
2020-12-31$โ‚น2.59 B-397.56%
2019-12-31$-โ‚น0.88 Billion-348.52%
2018-12-31$โ‚น0.35 B-6.58%
2017-12-31$โ‚น0.37 B-44.2%
2016-12-31$โ‚น0.67 B-28.33%
2015-12-31$โ‚น0.93 B121.93%
2014-12-31$โ‚น0.42 B150.01%
2013-12-31$โ‚น0.16 B-22.39%
2012-12-31$โ‚น0.21 B176.98%
2011-12-31$โ‚น78.71 M-482.71%
2010-12-31$-โ‚น20.57 Million-74.57%
2009-12-31$-โ‚น80.88 Million-18.95%
2008-12-31$-โ‚น99.79 Million4.72%
2007-12-31$-โ‚น95.29 Million18.47%
2006-12-31$-โ‚น80.44 Million
2006-03-31$-โ‚น0.36 Billion-1257.65%
2005-03-31$โ‚น30.63 M-2346.88%
2004-03-31$-โ‚น1.37 Million-240.83%
2003-03-31$โ‚น0.96 M-61.98%
2002-03-31$โ‚น2.54 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น1.929 T-354,334.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น46.87 Billion 8,503.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น229.36 B-42,206.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.637 T-300,702.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-โ‚น25.26 Billion 4,537.08%๐Ÿ‡บ๐Ÿ‡ธ USA